Correlation Between Dicerna Pharmaceuticals and Editas Medicine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dicerna Pharmaceuticals and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dicerna Pharmaceuticals and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dicerna Pharmaceuticals and Editas Medicine, you can compare the effects of market volatilities on Dicerna Pharmaceuticals and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dicerna Pharmaceuticals with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dicerna Pharmaceuticals and Editas Medicine.

Diversification Opportunities for Dicerna Pharmaceuticals and Editas Medicine

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Dicerna and Editas is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Dicerna Pharmaceuticals and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Dicerna Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dicerna Pharmaceuticals are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Dicerna Pharmaceuticals i.e., Dicerna Pharmaceuticals and Editas Medicine go up and down completely randomly.

Pair Corralation between Dicerna Pharmaceuticals and Editas Medicine

If you would invest (100.00) in Dicerna Pharmaceuticals on December 30, 2023 and sell it today you would earn a total of  100.00  from holding Dicerna Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Dicerna Pharmaceuticals  vs.  Editas Medicine

 Performance 
       Timeline  
Dicerna Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Dicerna Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Dicerna Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Editas Medicine 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Editas Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in April 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Dicerna Pharmaceuticals and Editas Medicine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dicerna Pharmaceuticals and Editas Medicine

The main advantage of trading using opposite Dicerna Pharmaceuticals and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dicerna Pharmaceuticals position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.
The idea behind Dicerna Pharmaceuticals and Editas Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing